We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Medtronic announced that the FDA approved ...

Routine placement of atrial leads is common during implantable cardioverter-defibrillator (ICD) implantation for primary prevention despite guidelines that discourage it—now there are new ...

Forty-eight patients were randomized to receive a single-chamber ICD and 52 for implantation of a dual-chamber ICD. Patient characteristics are shown in Table 1. No statistically significant ...

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a ...

BIOTRONIK has announced the Food and Drug Administration (FDA) has granted final approval for the BIOTRONIK Lumax 740 DX System. This novel device is a first-in-class implantable cardiac defibrillator ...

Introduction Studies showing that implantable cardioverter-defibrillators (ICDs) effectively prevent sudden cardiac death in high-risk patients have been conducted mostly on single-chamber ICDs ...

LAKE OSWEGO, Ore. -- BIOTRONIK today announced the publication of the SENSE Trial results in the Journal of Cardiovascular Electrophysiology, proving BIOTRONIK's DX system is equivalent to ...

A new study is questioning the benefits of dual-chamber implantable cardioverter-defibrillators. Dual-chamber ICDs, which are more expensive and more complicated to implant than single-chamber devices ...

Dublin, June 22, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Analysis and Forecast, ...

Patients receiving an implantable cardioverter-defibrillator (ICD) for primary prevention often receive a dual-chamber ICD. An analysis that included more than 32,000 patients receiving an ICD without ...